12 March 2008
Immtech Announces Update On Business Operations
22 February 2008
Immtech Focusing on New Infectious Disease Programs Following Discontinuation Of Development For Pafuramidine
19 February 2008
Immtech Investor Conference Call Scheduled For February 22, 2008
13 February 2008
Immtech Appoints Blythe Weigh As Strategic Advisor
11 February 2008
Immtech Reports Fiscal Third Quarter 2008 Results
06 February 2008
Immtech Investor Conference Call Scheduled for February 11, 2008
28 December 2007
Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
26 December 2007
Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
05 December 2007
Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine
聯絡資料
總公司
One North End Avenue
New York, NY 10282
熱線電話: 877.898.8038
電話 • 212.791.2911
傳真 • 212.791.2917
